110 results on '"Casanova, Ruben"'
Search Results
2. DNA-barcoded signal amplification for imaging mass cytometry enables sensitive and highly multiplexed tissue imaging
3. Establishing standardized immune phenotyping of metastatic melanoma by digital pathology
4. Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry — Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort
5. In vitro cell culture of patient derived malignant pleural and peritoneal effusions for personalised drug screening
6. Figure S2. Threshold analysis of tumor fragmentation in correlation with RFS and OS. from Morphoproteomic Characterization of Lung Squamous Cell Carcinoma Fragmentation, a Histological Marker of Increased Tumor Invasiveness
7. Figure S3. Biological processes associated with TF morphotypes from TCGA mRNAseq and WS Mass Spectrometry data. from Morphoproteomic Characterization of Lung Squamous Cell Carcinoma Fragmentation, a Histological Marker of Increased Tumor Invasiveness
8. Table S1. Complete list of proteins identifications. from Morphoproteomic Characterization of Lung Squamous Cell Carcinoma Fragmentation, a Histological Marker of Increased Tumor Invasiveness
9. Table S3. Association of TF scores with relapse-free survival. from Morphoproteomic Characterization of Lung Squamous Cell Carcinoma Fragmentation, a Histological Marker of Increased Tumor Invasiveness
10. Table S4. Association of human-based TF scores with OS and RFS. from Morphoproteomic Characterization of Lung Squamous Cell Carcinoma Fragmentation, a Histological Marker of Increased Tumor Invasiveness
11. Supplementary Figure 2 from Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma
12. Supplementary Figure S4 from Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma
13. PRoteomics IDEntifications database from Morphoproteomic Characterization of Lung Squamous Cell Carcinoma Fragmentation, a Histological Marker of Increased Tumor Invasiveness
14. Data from Morphoproteomic Characterization of Lung Squamous Cell Carcinoma Fragmentation, a Histological Marker of Increased Tumor Invasiveness
15. Table S2. Association of tumor fragmentation with clinico-pathological parameters. from Morphoproteomic Characterization of Lung Squamous Cell Carcinoma Fragmentation, a Histological Marker of Increased Tumor Invasiveness
16. Table S5. List of proteins associated with tumor fragmentation. from Morphoproteomic Characterization of Lung Squamous Cell Carcinoma Fragmentation, a Histological Marker of Increased Tumor Invasiveness
17. Supplementary Figure 3 from Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma
18. Data from Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma
19. Supplementary Figure Legends from Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma
20. Supplementary Tables from Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma
21. Supplementary Methods from Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma
22. Figure S1. Frequency distributions, intra-tumor heterogeneity and inter-observer variability for TF scores. from Morphoproteomic Characterization of Lung Squamous Cell Carcinoma Fragmentation, a Histological Marker of Increased Tumor Invasiveness
23. Statistical modeling and analysis of multiplexed imaging data
24. A Quantitative Pathology Approach to Analyze the Development of Human Cancer-Associated Tertiary Lymphoid Structures
25. Lung adenocarcinoma patients with malignant pleural effusions in hot adaptive immunity status have a longer overall survival
26. Lung Adenocarcinoma Patients with Malignant Pleural Effusions in Hot Adaptive Immunity Status Have a Longer Overall Survival
27. Lung adenocarcinoma patients with malignant pleural effusions in hot adaptive immunity status have a longer overall survival.
28. SCIM: universal single-cell matching with unpaired feature sets
29. The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support
30. Additional file 1 of In vitro cell culture of patient derived malignant pleural and peritoneal effusions for personalised drug screening
31. Enhanced prognostic stratification of neoadjuvant treated lung squamous cell carcinoma by computationally-guided tumor regression scoring
32. Enhanced prognostic stratification of neoadjuvant treated lung squamous cell carcinoma by computationally-guided tumor regression scoring
33. In vitro cell culture of patient derived malignant pleural and peritoneal effusions for personalised drug screening
34. Prognostic Immune Cell Profiling of Malignant Pleural Effusion Patients by Computerized Immunohistochemical and Transcriptional Analysis
35. Computer-based intensity measurement assists pathologists in scoring PTEN immunohistochemistry - Clinical associations in NSCLC patients of the ETOP Lungscape cohort
36. Prognostic Immune Cell Profiling of Malignant Pleural Effusion Patients by Computerized Immunohistochemical and Transcriptional Analysis
37. Morphoproteomic characterization of lung squamous cell carcinoma fragmentation, a histological marker of increased tumor invasiveness
38. Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma
39. Abstract A113: Harnessing lymphoid organ neogenesis as a novel prognostic biomarker and therapeutic target
40. A Quantitative Pathology Approach to Analyze the Development of Human Cancer-Associated Tertiary Lymphoid Structures
41. Computationally-Guided Development of a Stromal Inflammation Histologic Biomarker in Lung Squamous Cell Carcinoma
42. Non-internalizing antibody-drug conjugates and their anti-cancer activity
43. 3 / Automatic classification of non-small cell lung cancer histologic subtypes by deep learning
44. Computationally-Guided Development of a Stromal Inflammation Histologic Biomarker in Lung Squamous Cell Carcinoma
45. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma
46. FDG-PET/CT of non-small cell lung carcinoma under neo-adjuvant chemotherapy: background based adaptive volume metrics outperform TLG and MTV in predicting histopathological response
47. Identification of morphologic parameters affecting the prognosis of lung squamous cell carcinoma patients by computer-based morphometric analysis
48. Morphoproteomic Characterization of Lung Squamous Cell Carcinoma Fragmentation, a Histological Marker of Increased Tumor Invasiveness
49. Non-internalizing antibody-drug conjugates display potent anti-cancer activity upon proteolytic release of monomethyl auristatin E in the subendothelial extracellular matrix
50. Abstract 2264: Tumor fragmentation is a poor prognostic histologic biomarker for lung squamous cell carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.